US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose–Positron Emission Tomography Imaging: Southwest Oncology Group S0816

PURPOSE: Four US National Clinical Trials Network components (Southwest Oncology Group, Cancer and Leukemia Group B/Alliance, Eastern Cooperative Oncology Group, and the AIDS Malignancy Consortium) conducted a phase II Intergroup clinical trial that used early interim fluorodeoxyglucose positron emi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Press, Oliver W., Li, Hongli, Schöder, Heiko, Straus, David J., Moskowitz, Craig H., LeBlanc, Michael, Rimsza, Lisa M., Bartlett, Nancy L., Evens, Andrew M., Mittra, Erik S., LaCasce, Ann S., Sweetenham, John W., Barr, Paul M., Fanale, Michelle A., Knopp, Michael V., Noy, Ariela, Hsi, Eric D., Cook, James R., Lechowicz, Mary Jo, Gascoyne, Randy D., Leonard, John P., Kahl, Brad S., Cheson, Bruce D., Fisher, Richard I., Friedberg, Jonathan W.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2016
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4966513/
https://ncbi.nlm.nih.gov/pubmed/27069074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.63.1119
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados